G
Glenmark Pharmaceuticals Ltd
PharmaceuticalsMidcap
About the company
Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
Performance
- Stock
- Loading Stock value
—
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 45.51 | 45.27 |
| PB Ratio | 7.00 | 5.97 |
| Dividend Yield | 0.11% | 0.52% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions